|
HeartStart FR2+
Pediatric Defibrillation
HeartStart FR2-series
defibrillators can be
used safely on
children (under 8 years
or 55 pounds), when
equipped with HeartStart
FR2 Infant/Child
Defibrillator Pads.
These special-purpose
pads attenuate the
defibrillator's shock
from the adult dose of
150 Joules of SMART
Biphasic therapy to just
50 Joules, an
appropriate dose for
infants and small
children.
The pads' design was
carefully though out to
ensure that even for the
most inexperienced user
under the most stressful
circumstances, it is
instantly obvious that
these pads are for
treating infants and
children. The packaging,
graphics and pink
bear-shaped connector
clearly communicate
"pediatric use".
Frequently Asked
Questions
How does the
pediatric-ready FR2+
work?
Using the
defibrillator is simple.
The responder presses
the green button at the
front of the FR2+ to
power-up the unit, then
places the special
infant/child
defibrillator pads on
the victim. Next, the
responder plugs the pads
connector into the
defibrillator. The
device automatically
analyzes the heart
rhythm and determines
whether a shock is
needed. If a shockable
rhythm is detected, the
FR2+ instructs the
responder to deliver
defibrillation therapy.
Back to top
Is 50 Joules
appropriate for all
children under 8 years
old, including infants?
Yes. The use of a
single level of energy
is an appropriate model
for an AED. It is
analogous to our
successful
non-escalating adult
therapy of 150 J for
older children and
adults of all sizes. The
use of a single energy
dose eliminates the
necessity to guess the
child's age and/or
weight and adjust the
dose accordingly - a
protocol complication
that is not suitable for
less experienced
responders. 50 J
provides sufficient
energy to ensure that
children up to 8 years
or 55 pounds receive at
least 2 J/kg, per AHA
guidelines.6
An attenuated 50 Joules
from the FR2+ was tested
on pigs with long
downtime VF. These pigs
had weights that varied
from 3.5 kg (comparable
to a human infant) to 25
kg (comparable to a
typical 8 year old
child). Resuscitation
was always successful
and all survived. For
all, post-resuscitation
hemodynamic and
myocardial function
quickly returned to
baseline values.2
In fact, the smallest
animals showed the
fastest return to
baseline cardiac
performance! One can
conclude that 50 J works
well for the entire size
range seen in infants
and children under 8
years, without
detrimental side
effects.
Back to top
What about human
studies?
A study tested the
Patient Analysis System
algorithm of the FR2+
for sensitivity and
specificity on a
database of 696 human
pediatric rhythms.1
The Patient Analysis
System performed
exceptionally well for
sensitivity (correctly
deciding to shock) and
specificity (correctly
deciding not to shock).
VF sensitivity was 96%
and specificity was
100%, both well above
the AHA goals for AEDs.
The specificity results
are particularly
significant because one
never wants to risk
shocking a child
unnecessarily. This is a
concern for those
defibrillators with
algorithms that base
shock/no shock decisions
on heart rate alone
because children tend to
experience very fast
heart rates under high
stress conditions, yet a
shock may be
inappropriate. The
analysis algorithm of
the FR2+ demonstrated
specificity results that
preclude inappropriate
shocks because it
considers more than just
heart rate. It considers
the combination of rate,
conduction, amplitude,
and stability.
For ethical reasons,
it is virtually
impossible to perform
prospective and
statistically
significant
defibrillation clinical
trials on children to
test for shock efficacy
using actual shocks. On
the other hand, pig
physiology is highly
comparable to humans,
making them good
surrogate subjects.
Using pigs to test new
therapies is a generally
accepted practice. The
research approach and
results are described in
the Summary of Safety
and Effectiveness that
was considered by the
FDA 9 years prior to
clearing the FR2-series
defibrillators for
pediatric use (a copy of
this summary is
available from Philips
upon request).
Back to top
Does the FR2+
still do impedance
compensation with these
pads?
Yes. The
defibrillator's
algorithm performs
impedance compensation
exactly as it does with
adult pads.
Back to top
Why do these
infant/child pads have a
pink teddy-bear
connector?
One of Philips'
guiding requirements is
that AEDs must be
completely intuitive for
the least experienced,
and most stressed
responder. It is vital
that the correct pads
are chosen for adults
and for children,
especially since the
infant/child pads would
deliver a therapy that
may be ineffective on
adults. Choosing the
right pads must be
automatic, with little
thinking required. So
Philips employed a
tiered strategy which
begins with simple,
identifiable packaging
and then follows with a
substantially different
connector that clearly
communicates at an
instinctive level
"Child!" A pink
teddy-bear poking out of
an AED will give the
responder pause and an
opportunity to verify
that the correct pads
are being used.
Back to top
I see
Anterior/Posterior (A/P)
pad placement is used.
Why?
In extensive user
testing, responders
found it much easier to
perform good pad
placement using A/P
placement (i.e., one pad
on the chest and one on
the back) on infants'
and small childrens'
tiny torsos.
Back to top
Does this mean
Anterior/Anterior (A/A)
placement won't work?
Philips has data
demonstrating good pad
performance when placed
correctly in the A/A
position, however A/P
positioning is
recommended due to the
reasons cited above. A/A
placement is shown in
the infant/child pads
user guide as an
alternative position,
however it is not shown
on the packaging in
order to keep
instructions simple for
inexperienced
responders.
Back to top
What is the
impact on training?
From the device
perspective,
defibrillator use
remains simple if
instructors direct
students to simply "look
at the pictures on the
pads and place them as
shown." Because the
prompts of the FR2+ are
the same for adult and
pediatric patients, only
proper infant/child pad
positioning needs to be
added to FR2+ training.
However, as with adult
defibrillator training,
it is important that
FR2+ users who are
likely to use the
defibrillator on
pediatric patients
receive training in
pediatric basic life
support (BLS) techniques
prior to or at the same
time they learn
pediatric
defibrillation.
Philips has developed
a pediatric supplement
for the FR2 Instructor
Toolkit and reusable
infant/child training
pads are available.
Philips is also working
with major emergency
care training providers
to update their
materials to include
appropriate information
on pediatric
defibrillation with the
FR2+ defibrillator.
Back to top
These pads can
only be used with the
FR2 or FR2+, not with
manual defibrillators.
Why?
This is a necessary
safety precaution. It
ensures that ALS
responders arriving at
the scene with manual
defibrillators do not
unplug the FR2
infant/child pads from
the AED, plug it into
their manual unit at
handoff, and
inadvertently select an
energy level that does
not take into account
the pads' attenuator.
This would result in a
potentially ineffective
shock at 1/3 the energy
level the responder
intended. So the pads'
connector has a shape
that only fits the FR2
or FR2+. Since Philips
offers adapters that
enable handoff to manual
defibrillators, the
connector's shape also
keeps the pads from
working with these
adapters.
Back to top
What is the
AHA's position on these
pads?
The AHA will be
evaluating data on the
use of Philips
defibrillators on small
children. For now, AED
use on small children
retains its
"indeterminate" level of
evidence within the AHA
guidelines.6
This was the status
initially given to
automated external
defibrillators
delivering adult doses
of electric therapy to
small children, long
before the introduction
of this ground-breaking
pediatric capability in
Philips automated
external defibrillators.
It is important to
understand what this
status means.
The classification
"indeterminate" means
"Available evidence
insufficient to support
a final class decision."6
The AHA summarizes the
interpretation of this
status as follows,
"Interventions classed
indeterminate can still
be recommended for use,
but reviewers must
acknowledge that
research
quantity/quality fall
short of supporting a
final class decision...
Indeterminate is limited
to promising
interventions."6
In a recent position
statement,10
the AHA reviewed its
previous concerns about
the lack of data
regarding an AED's
ability to accurately
make shock/no shock
decisions and then
deliver appropriate
doses to small children
in the event of a shock
decision. In response to
the introduction of
Phillips' pediatric
capability, the AHA
said, "The development
of this new pad and
cable system for this
AED is a very
encouraging development
that helps address the
AHA's safety concerns
about electrical
'overdosing' of infants
and children." With
regard to the recently
released clinical trial
of the Philips SMART
Analysis system,1
the AHA said, "The
results of this recent
study are highly
encouraging and suggest
that the rhythm
detection of the AED
tested may perform well
when used to actually
assess the cardiac
rhythm of children."
More recently, the
Resuscitation Council
for the United Kingdom
took this position on
Philips' pediatric
capability:
"One manufacturer has
[clearance] for use of
its defibrillator with
special pediatric pads
which deliver a fixed
energy level of 50
Joules. This machine
would be preferable to a
defibrillator delivering
only "adult" fixed doses
in situations where
children may require
defibrillation and a
fully adjustable
defibrillator is
unavailable or
unsuitable."11
Back to top
Why is this
capability important?
Children who might
have been saved die from
cardiac arrest. Broadly
deployed new automated
external defibrillator
technology affords the
opportunity for early
defibrillation within
minutes of cardiac
arrest onset, which is
now the standard of care
for victims of cardiac
arrest over 8 years of
age. Unfortunately,
children under 8 have
not received that same
standard of care.
When a small child
suffers cardiac arrest,
many response protocols
have traditionally
called for basic CPR
without automated
external defibrillator
use until a paramedic
with a manual
defibrillator arrives.
Treatment may be
tragically delayed while
awaiting paramedic care.
By the time a paramedic
arrives, hope of
successful resuscitation
is severely diminished.
This can be devastating.
Philips wants to change
things and enable the
saving of more kids'
lives. With the
demonstrated ability of
our FR2-series*
defibrillators to
accurately analyze
pediatric ECG rhythms1
and the availability of
special infant/child
defibrillator pads which
reduce shock energy to a
level appropriate for
children, 2
the tools are available
to help save precious
young lives.
*FR-series includes
all models of FR2 and
FR2+ defibrillators.
Throughout this
document, references to
the FR2+ also apply to
the FR2.
Back to top
- Cecchin,
et al. Is Arrhythmia
Detection by
Automatic External
Defibrillator
Accurate for
Children?
Sensitivity and
Specificity of an
AED Algorithm in 696
Pediatric
Arrhythmias.
Circulation 2001;
103:2483-2488, May
22, 2001.
- Tang, et
al. Pediatric Fixed
Energy Biphasic
Waveform
Defibrillation Using
a Standard AED and
Special Pediatric
Electrodes.
Supplement to
Circulation, Vol
102, No 18, October
31, 2000, II-437.
- Sirbaugh,
et al. A
Prospective,
Population - Based
Study of the
Demographics,
Epidemiology,
Management and
Outcome of Out of
Hospital Pediatric
Cardiopulmonary
Arrest. Annals of
Emergency Medicine,
Feb 99, 33:2
174-184.
- Young and
Seidel. Pediatric
Cardiopulmonary
Resuscitation: A
Collective Review.
Annals of Emergency
Medicine, Feb 99,
33:2 195-205.
- Mogayzel,
et al. Out of
Hospital Ventricular
Fibrillation in
Children and
Adolescents: Causes
and Outcomes. Annals
of Emergency
Medicine, April 95,
25:4 484-491.
- American
Heart Association
Guidelines 2000.
Supplement to
Circulation, Volume
102 Number 8 August
22, 2000.
- Safranek,
et al. The
Epidemiology of
Cardiac Arrest in
Young Adults. Annals
of Emergency
Medicine 1992:21
1102-1106.
- Hickey,
et al. Pediatric
Patients Requiring
CPR in the
Prehospital Setting.
Annals of Emergency
Medicine April 95,
25:4 495-501.
- FDA Talk
Paper: FDA Clears
First External
Defibrillator for
Use on Young
Children; May 4,
2001.
- American
Heart Association
Position Statement:
Use of Automated
External
Defibrillators
(AEDs) on Infants
and Young Children,
July 2, 2001.
- Dr Robert
Bingham, Chairman,
Resuscitation
Council (UK).
Resuscitation
Council Position
Statement: The use
of biphasic
defibrillators and
AEDs in children.
Revised July 2001.
5990-0636EN
Back to top |